Search research articles
Contact Us
Filters
Showing results (81-90 of 97) with videos related to
Page
of 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
February 21, 2021
Toward Individualized Voxel-Level Dosimetry for Radiopharmaceutical Therapy
Ying Xiao, Emilie Roncali, Robert Hobbs, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 23, 2016
How Will Big Data Improve Clinical and Basic Research in Radiation Therapy?
Barry S Rosenstein, Jacek Capala, Jason A Efstathiou, et al.
Translational Oncology
|
April 29, 2014
The Quantitative Imaging Network: NCI's Historical Perspective and Planned Goals
Laurence P Clarke, Robert J Nordstrom, Huiming Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 9, 2005
Inverse treatment planning based on MRI for HDR prostate brachytherapy
Deborah Citrin, Holly Ning, Peter Guion, et al.
Theranostics
|
February 28, 2019
Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles
Minati Satpathy, Liya Wang, Rafal J Zielinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2022
Tumor Heterogeneity Research and Innovation in Biologically Based Radiation Therapy From the National Cancer Institute Radiation Research Program Portfolio
Jeffrey C Buchsbaum, Michael G Espey, Ceferino Obcemea, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 5, 2018
Accurate, Precision Radiation Medicine: A Meta-Strategy for Impacting Cancer Care, Global Health, and Nuclear Policy and Mitigating Radiation Injury From Necessary Medical Use, Space Exploration, and Potential Terrorism
C Norman Coleman, Pataje G S Prasanna, Eric J Bernhard, et al.
Oncotarget
|
August 26, 2014
Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer
Siti Norasikin Mohd Nafi, Daniele Generali, Gabriela Kramer-Marek, et al.
Journal of Neuro-Oncology
|
May 17, 2003
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden
Jacek Capala, Britta H Stenstam, Kurt Sköld, et al.
Oncotarget
|
June 23, 2014
ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer
Katharina Feldinger, Daniele Generali, Gabriela Kramer-Marek, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 97) with videos related to
Sort By:
Page
of 10
International Journal of Radiation Oncology, Biology, Physics
|
February 21, 2021
Toward Individualized Voxel-Level Dosimetry for Radiopharmaceutical Therapy
Ying Xiao, Emilie Roncali, Robert Hobbs, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 23, 2016
How Will Big Data Improve Clinical and Basic Research in Radiation Therapy?
Barry S Rosenstein, Jacek Capala, Jason A Efstathiou, et al.
Translational Oncology
|
April 29, 2014
The Quantitative Imaging Network: NCI's Historical Perspective and Planned Goals
Laurence P Clarke, Robert J Nordstrom, Huiming Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 9, 2005
Inverse treatment planning based on MRI for HDR prostate brachytherapy
Deborah Citrin, Holly Ning, Peter Guion, et al.
Theranostics
|
February 28, 2019
Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles
Minati Satpathy, Liya Wang, Rafal J Zielinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2022
Tumor Heterogeneity Research and Innovation in Biologically Based Radiation Therapy From the National Cancer Institute Radiation Research Program Portfolio
Jeffrey C Buchsbaum, Michael G Espey, Ceferino Obcemea, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 5, 2018
Accurate, Precision Radiation Medicine: A Meta-Strategy for Impacting Cancer Care, Global Health, and Nuclear Policy and Mitigating Radiation Injury From Necessary Medical Use, Space Exploration, and Potential Terrorism
C Norman Coleman, Pataje G S Prasanna, Eric J Bernhard, et al.
Oncotarget
|
August 26, 2014
Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer
Siti Norasikin Mohd Nafi, Daniele Generali, Gabriela Kramer-Marek, et al.
Journal of Neuro-Oncology
|
May 17, 2003
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden
Jacek Capala, Britta H Stenstam, Kurt Sköld, et al.
Oncotarget
|
June 23, 2014
ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer
Katharina Feldinger, Daniele Generali, Gabriela Kramer-Marek, et al.
Page
of 10